Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation

Qing Wang1, Gloria J Guzmán Pérez-Carrillo2, Maria Rosana Ponisio1

  • 1Department of Radiology, Washington University in St. Louis, St. Louis, Missouri, United States of America.

Plos One
|November 15, 2019
PubMed
Abstract

Insights

Heterogeneity Diffusion Imaging (HDI) offers a novel approach to characterize primary brain tumors, outperforming conventional MRI. This diffusion MRI method accurately quantifies tumor components and perfusion, aiding in noninvasive tumor grading and biopsy planning.

Area of Science:

  • Neuroimaging
  • Oncology
  • Medical Physics

Background:

  • Primary brain tumors exhibit complex heterogeneity, including tumor cells, neural/glial tissues, edema, and vasculature.
  • Conventional MRI techniques struggle to adequately assess these diverse pathological components and capillary blood perfusion.
  • Accurate characterization is crucial for diagnosis, grading, and treatment planning of brain tumors.

Purpose of the Study:

  • To introduce and evaluate Heterogeneity Diffusion Imaging (HDI), a novel diffusion MRI-based method.
  • To assess HDI's capability in simultaneously detecting and characterizing multiple tumor pathologies and capillary blood perfusion.
  • To compare HDI metrics with conventional MRI and dynamic susceptibility contrast (DSC) perfusion imaging in primary brain tumors.

Main Methods:

  • Seven adult patients with primary brain tumors underwent both standard MRI protocols and the HDI protocol.
  • Tumor sampling sites were correlated with imaging data for quantification.
  • HDI-derived metrics were compared between World Health Organization (WHO) II and III tumor groups and correlated with DSC-derived cerebral blood volume (CBV).

Main Results:

  • Conventional apparent diffusion coefficient did not differentiate between WHO II and III tumor groups.
  • HDI revealed significantly elevated slow hindered diffusion fraction in WHO III tumors compared to WHO II.
  • HDI-derived perfusion fraction and DSC-derived CBV were significantly higher in WHO III tumors; HDI perfusion fraction correlated strongly with DSC-CBV.

Conclusions:

  • HDI offers superior accuracy and specificity over conventional apparent diffusion coefficient for brain tumor characterization.
  • HDI can effectively separate and quantify tumor cell fraction, packing density, edema, and capillary blood perfusion.
  • HDI shows significant promise for improved microenvironment characterization, noninvasive tumor grading, and biopsy planning.

Related Concept Videos